Phazar: A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN [ISRCTN16783472]
暂无分享,去创建一个
A. Mead | C. Yap | J. Byrne | C. Harrison | T. Somervaille | D. Bowen | E. Gudgin | S. Knapper | M. Drummond | R. Fletcher | C. Brierley | F. Clark | S. Narayanan | Aimee E Jackson | C. Gaskell | D. Milojkovic